Contrarily, FLRT2 downregulation was observed in colorectal cancer and breast cancer, and FLRT2 inhibited colorectal cancer (Guo et al., 2020) and breast cancer (Bae et al., 2017) progression. Here, FLRT2 is linked to breast carcinoma.